Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116791) titled 'The study checks whether a new Clozapine 100 mg tablet works the same as the marketed CLOZARIL tablet in patients with schizophrenia who are already taking Clozapine regularly, with both tablets being taken after a standard breakfast' on Sept. 1.

Study Type: BA/BE

Study Design: Randomized, Crossover Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Centralized Blinding and masking:Open Label

Primary Sponsor: Bionpharma, Inc.,

Condition: Health Condition 1: F209- Schizophrenia, unspecified

Intervention: Intervention1: Clozapine 100 mg...